%0杂志文章%@ 1438- 8871% I JMIR出版物%V 24卡塔尔世界杯8强波胆分析% N 7% P e37430% T使用电子病历集成移动应用程序对2型糖尿病患者进行个性化糖尿病自我护理的疗效:6个月随机对照试验%A Lee,Eun Young %A Cha,Seon-Ah %A Yun,Jae-Seung %A Lim, sunyoung %A Lee,Jin-Hee %A Ahn,Yu-Bae %A Yoon, kuno - ho %A Hyun,Min Kyung %A Ko,Seung-Hyun %+内科内分泌代谢科，韩国天主教大学医学院圣文森特医院，93,paldal区中央大道，水原，16247，大韩民国，82 0312498155，shkoh718@gmail.com %K 2型糖尿病%K数字健康%K移动健康%K移动健康%K移动应用%K自我监测血糖%K手机%D 2022 %7 28.7.2022 %9原始论文%J J医学互联网Res %G英语%X背景:一个结合技术和网络指导的系统可以帮助治疗糖尿病等慢性疾病。然而，由于不同的干预措施和不同的随访时间，应用程序在移动健康(mHealth)干预措施中的有效性尚不确定和不清楚。此外，随机对照试验数据有限，缺乏长期随访，特别是集成到电子病历中的应用程序。目的:我们旨在评估一款电子病历集成的个性化糖尿病自我护理手机应用程序对2型糖尿病患者血糖控制的影响，该应用程序侧重于血糖的自我监测和生活方式的改变。方法:在一项26周、三组、随机、对照、开放标签、平行组试验中，招募糖化血红蛋白(HbA1c)≥7.5%的2型糖尿病患者。移动健康干预包括自我监测血糖，自动传输血糖、饮食和体育活动咨询数据(iCareD系统)。参与者被随机分配到以下三组:常规护理(UC)，移动糖尿病自我护理(MC)，以及医生个性化双向反馈的MC (MPC)。主要结果是26周时糖化血红蛋白水平的变化。 In addition, diabetes-related self-efficacy, self-care activities, and satisfaction with the iCareD system were assessed after the intervention. Results: A total of 269 participants were enrolled, and 234 patients (86.9%) remained in the study at 26 weeks. At 12 weeks after the intervention, the mean decline in HbA1c levels was significantly different among the 3 groups (UC vs MC vs MPC: −0.49% vs −0.86% vs −1.04%; P=.02). The HbA1c level decreased in all groups; however, it did not differ among groups after 26 weeks. In a subgroup analysis, HbA1c levels showed a statistically significant decrease after the intervention in the MPC group compared with the change in the UC or MC group, especially in patients aged <65 years (P=.02), patients with a diabetes duration of ≥10 years (P=.02), patients with a BMI of ≥25.0 kg/m2 (P=.004), patients with a C-peptide level of ≥0.6 ng/mL (P=.008), and patients who did not undergo treatment with insulin (P=.004) at 12 weeks. A total of 87.2% (137/157) of the participants were satisfied with the iCareD system. Conclusions: The mHealth intervention for diabetes self-care showed short-term efficacy in glycemic control, and the effect decreased over time. The participants were comfortable with using the iCareD system and exhibited high adherence. Trial Registration: Clinical Research Information Service, Republic of Korea KCT0004128; https://tinyurl.com/bdd6pa9m %M 35900817 %R 10.2196/37430 %U //www.mybigtv.com/2022/7/e37430 %U https://doi.org/10.2196/37430 %U http://www.ncbi.nlm.nih.gov/pubmed/35900817